PROXYMED, INC.
Table of Contents

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 3, 2006
PROXYMED, INC.
(Exact name of registrant as specified in its charter)
         
FLORIDA   000-22052   65-0202059
(State or other jurisdiction of   (Commission File No.)   (IRS Employer
incorporation)       Identification No.)
1854 Shackleford Court, Suite 200,
Norcross Georgia 30093-2924

(Address of principal executive offices)
(770) 806-9918
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Item 9.01. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
EX-99.1 PRESS RELEASE DATED FEBRUARY 3, 2006


Table of Contents

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On January 26, 2006, ProxyMed, Inc. (the “Company”) accepted the resignation of Kevin M. McNamara, Chairman of the Board of Directors of the Company to be effective January 31, 2006 and appointed Braden R. Kelly to the Company as “acting” Chairman of the Board. The Company is evaluating internal and external candidates for a permanent Chairman of the Board. A copy of the Company’s press release is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
Exhibits
As described in Item 5.02 of this Report, the following Exhibit is furnished as part of this Current Report on Form 8-K.
     
Exhibit No.   Description
 
99.1
  Press release of the Company dated February 3, 2006.

 


Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
    ProxyMed, Inc.
 
       
Date: February 3, 2006
  By:        /s/ John G. Lettko
 
       
 
      John G. Lettko
 
      Chief Executive Officer

3


Table of Contents

EXHIBIT INDEX
     
Exhibit No.   Description
 
99.1
  Press Release dated February 3, 2006.

4